| |
| |
|
| Insider
Information: |
Mueller Brian |
| Relationship: |
|
| City: |
Novato |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
82,159 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,395,452 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
82,159 |
|
|
| Total
Value |
$6,395,452 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biomarin Pharmaceutical Inc |
BMRN |
EVP, Chief Financial O... |
2024-05-30 |
72,159 |
|
0 |
Premium* |
|
|
Anthera Pharmaceuticals Inc |
ANTH |
|
2015-12-23 |
10,000 |
2015-12-23 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
139 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2013-05-02 |
4 |
S |
$65.35 |
$610,354 |
D/D |
(9,331) |
9,403 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2023-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
9,630 |
62,266 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2023-06-29 |
4 |
D |
$88.93 |
$869,735 |
D/D |
(9,780) |
45,805 |
0 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
|
– • – |
2015-12-23 |
4 |
OE |
$2.89 |
$28,900 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2021-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
10,110 |
38,800 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2022-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
11,040 |
40,749 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2024-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
11,400 |
92,648 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2012-05-08 |
4 |
S |
$37.50 |
$589,050 |
D/D |
(15,708) |
13,684 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2012-05-08 |
4 |
OE |
$11.74 |
$216,967 |
D/D |
15,708 |
29,392 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2012-11-15 |
4 |
OE |
$14.39 |
$477,085 |
D/D |
15,812 |
31,152 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2012-11-15 |
4 |
AS |
$50.00 |
$790,600 |
D/D |
(15,812) |
15,340 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2024-03-15 |
4 |
D |
$83.87 |
$1,743,573 |
D/D |
(20,789) |
71,859 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2023-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
24,890 |
52,636 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2024-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
35,125 |
81,248 |
0 |
- |
|
139 Records found
|
|
Page 6 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
